Zobrazeno 1 - 4
of 4
pro vyhledávání: '"E. Masson Frenet"'
Autor:
E. Masson Frenet, Cynthia Romeo, Maria S. Albano, Pablo Rubinstein, Andromachi Scaradavou, Ludy Dobrila, Dorothy Sung, Dan Zamfir, Michal Tarnawski
Publikováno v:
Cytotherapy. 22:S154
Background & Aim One of the most important attributes of cord blood is the prompt availability of high quality cell therapy products for clinical use. To achieve this, the NCBP has implemented a strong infrastructure supporting CBU search, selection,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::07fe72afa72773b39bbb6d3ed99c72a4
https://doi.org/10.1016/j.jcyt.2020.03.319
https://doi.org/10.1016/j.jcyt.2020.03.319
Autor:
Dan Zamfir, Andromachi Scaradavou, Tracy Zhu, Dorothy Sung, Ludy Dobrila, Maria S. Albano, E. Masson Frenet, Pablo Rubinstein, Michal Tarnawski, Chiseko Watanabe
Publikováno v:
Cytotherapy. 21:S53-S54
Background & Aim To evaluate the impact of cryopreservation and storage on CBU quality/potency, segment evaluation is performed prior to release for transplant. Although FACT provides broad guidelines, interpretation of CBU segment results remains a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5c156195faf9b8d97f2e0ea4945876bc
https://doi.org/10.1016/j.jcyt.2019.03.422
https://doi.org/10.1016/j.jcyt.2019.03.422
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Chaekal OK; Division of Hematology/Oncology and.; Division of Pathology, Department of Medicine, Weill Cornell Medicine, New York Presbyterian Hospital, New York, NY., Scaradavou A; National Cord Blood Program, New York Blood Center, New York, NY; and.; Stem Cell Transplantation and Cellular Therapies, MSK Kids, Memorial Sloan Kettering Cancer Center, New York, NY., Masson Frenet E; National Cord Blood Program, New York Blood Center, New York, NY; and., Albano MS; National Cord Blood Program, New York Blood Center, New York, NY; and., Cushing M; Division of Pathology, Department of Medicine, Weill Cornell Medicine, New York Presbyterian Hospital, New York, NY., Desai P; Division of Hematology/Oncology and., Dobrila L; National Cord Blood Program, New York Blood Center, New York, NY; and., Gergis U; Division of Hematology/Oncology and., Guarneri D; Division of Hematology/Oncology and., Hsu JM; Division of Hematology/Oncology and., Lee S; Division of Hematology/Oncology and., Mayer SA; Division of Hematology/Oncology and., Phillips AA; Division of Hematology/Oncology and., Orfali N; Division of Hematology/Oncology and., Ritchie EK; Division of Hematology/Oncology and., Roboz GJ; Division of Hematology/Oncology and., Romeo C; National Cord Blood Program, New York Blood Center, New York, NY; and., Samuel MS; Division of Hematology/Oncology and., Shore T; Division of Hematology/Oncology and., van Besien K; Division of Hematology/Oncology and.
Publikováno v:
Blood advances [Blood Adv] 2020 Oct 27; Vol. 4 (20), pp. 5146-5156.